Virtual Visits in Heart Failure Care Transitions (VIV-HF)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03675828|
Recruitment Status : Completed
First Posted : September 18, 2018
Last Update Posted : September 25, 2019
|Condition or disease||Intervention/treatment||Phase|
|Heart Failure||Behavioral: Virtual Visit||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||116 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Virtual Visits in Heart Failure Care Transitions|
|Actual Study Start Date :||August 7, 2018|
|Actual Primary Completion Date :||August 28, 2019|
|Actual Study Completion Date :||August 28, 2019|
Experimental: Virtual Visit
In this arm, the 7-day post discharge visit will be completed by a scheduled virtual visit with a member of the study team using the Cleveland Clinic Online Express Care application on a computer or a tablet/phone.
Behavioral: Virtual Visit
The Cleveland Clinic Express Care Online application will be used in this intervention. The subjects will have a virtual consult with a clinician from the study team that will mirror an experience had at an outpatient post-discharge visit, including review of systems and medications.
No Intervention: Outpatient Clinic
In this arm, the 7-day post discharge visit will be completed by a standard-of-care, in-person outpatient visit with a member of the study team in the heart failure clinic.
- Proportion of completed post discharge visits via virtual visit or in outpatient setting [ Time Frame: 12 months ]Proportion of patients who complete 7-day post discharge appointment (virtually or in-person)
- 45-day unplanned readmission and death measures stratified by visit method (virtually or in-person) [ Time Frame: 12 months ]Composite and individual components of unscheduled all-cause first occurrence of (a.) hospital readmission, (b.) emergency department visit, or (c.) death, in the first 45 days after hospital discharge.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03675828
|United States, Ohio|
|Cleveland, Ohio, United States, 44195|
|Principal Investigator:||Wai Hong Wilson Tang, MD||The Cleveland Clinic|